Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants
Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants
Randomised, placebo-controlled, double-blind efficacy study of the emollient V0034CR in addition to a moderately potent corticosteroid in the acute phase of treatment of atopic dermatitis in infants
Statut
Status :
Terminé
Type d'étude
Phase III
Age Min.
-
Age Max.
-
Genre
Tous
Aire thérapeutique :
Dermatologie
Maladie :
Dermatite atopique
Traitement :
Dexeryl®
Phase :
Phase III
Date de début de l'étude :
19 Novembre 2005
End date :
22 Juin 2006
Identifiant de l'essai :
V00034 CR 304
Identifiant EudraCT/CTIS :
2005-002803-18
Envoyer par email